DS-234

N/A

Report date: 2026/03/10 20:00:16

Base Information

Drug NameDS-234
Drug Alias NameDS-234ARQ-234
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionCell surface glycoprotein CD200 receptor 1 agonists
TargetsCell surface glycoprotein CD200 receptor 1
Therapy Area/IndicationsEczemaDermatitis, Atopic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesDucentis BioTherapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesArcutis Biotherapeutics IncDucentis BioTherapeutics Ltd
Inactive CompaniesN/A
Active IndicationsEczemaDermatitis, Atopic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A